The role of tumor microenvironment in resistance to anti-angiogenic therapy [version 1; referees: 2 approved]
Anti-angiogenic therapy has been demonstrated to increase progression-free survival in patients with many different solid cancers. Unfortunately, the benefit in overall survival is modest and the rapid emergence of drug resistance is a significant clinical problem. Over the last decade, several mech...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-03-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-326/v1 |